Recall Register

Food, drugs, devices › Fougera Pharmaceuticals Inc.

Drug recall: Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. F

FDA enforcement event 68683 · Class III · initiated 3 Jul 2014 · status Terminated · terminated 7 Dec 2015

DrugVoluntary: Firm initiated2 product recordsMelville, NY

Fougera Pharmaceuticals Inc. (Melville, NY) initiated this drug recall on 3 Jul 2014; FDA lists 2 product records under event 68683, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 27% of the 313 drug enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 7 Dec 2015. Initiation: voluntary: firm initiated. Fougera Pharmaceuticals Inc. has 7 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Fougera Pharmaceuticals Inc., Melville, NY.

Reason for recall

"Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry."

Distribution

"Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-1440-2014Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0337-60.111,388 BottlesClass IIITerminated23 Jul 2014
D-1441-2014Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0336-60.3,594 BottlesClass IIITerminated23 Jul 2014

Context

27%of 2014 drug events are Class III313 events that year
2product records in this eventfirm median: 1
7events on this register for the firm

Other enforcement events for Fougera Pharmaceuticals Inc.

InitiatedProduct (first record)TypeClassRecords
2 Mar 2017Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., MDrugClass II1
28 Aug 2014FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET DrugClass II1
29 Jan 2014Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera PharDrugClass III1
18 Nov 2013KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, NDrugClass III1
18 Jul 2012Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals IDrugClass III1
7 Jun 2012Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera PhDrugClass III1

All 7 events for Fougera Pharmaceuticals Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 7 Dec 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.